Regulation 20 Modifications to clinical trial approvalF1
A modification to a clinical trial approval may be made—
(a)
by the licensing authority or the ethics committee, in accordance with regulation 21; or
(b)
by the sponsor, in accordance with regulations 22, 22A and 22B.
Annotations
Textual amendments
- F1
Regs. 14-26 substituted (28.4.2026) by The Medicines for Human Use (Clinical Trials) (Amendment) Regulations 2025 (S.I. 2025/538), regs. 1(2), 14